Nakatsuka N, Moorjani P, Rai N, et al. The promise of discovering population-specific disease-associated genes in South Asia. Nat Genet. 2017;49(9):1403-1407. doi:10.1038/ng.3917.

Bolze A, Boisson B, Bosch B, et al. Incomplete penetrance for isolated congenital asplenia in humans with mutations in translated and untranslated exons. Proc Natl Acad Sci U S A. 2018;115(34):E8007-E8016. doi:10.1073/pnas.1805437115.

Udler MS, Kim J, von Grotthuss M, et al. Type 2 diabetes genetic loci informed by multi-trait associations point to disease mechanisms and subtypes: A soft clustering analysis. PLoS Med. 2018;15(9):e1002654. doi:10.1371/journal.pmed.1002654.

Perić S, Glumac JN, Topf A, et al. A novel recessive TTN founder variant is a common cause of distal myopathy in the Serbian population. Eur J Hum Genet. 2017;25(5):572-581. doi:10.1038/ejhg.2017.16.

Lee J-M, Gillis T, Mysore JS, et al. Common SNP-based haplotype analysis of the 4p16.3 Huntington disease gene region. Am J Hum Genet. 2012;90(3):434-44. doi:10.1016/j.ajhg.2012.01.005.

Moorjani P, Patterson N, Loh P-R, et al. Reconstructing Roma history from genome-wide data. PLoS One. 2013;8(3):e58633. doi:10.1371/journal.pone.0058633.

Wang SR, Agarwala V, Flannick J, et al. Simulation of Finnish population history, guided by empirical genetic data, to assess power of rare-variant tests in Finland. Am J Hum Genet. 2014;94(5):710-20. doi:10.1016/j.ajhg.2014.03.019.

Lim ET, Würtz P, Havulinna AS, et al. Distribution and medical impact of loss-of-function variants in the Finnish founder population. PLoS Genet. 2014;10(7):e1004494. doi:10.1371/journal.pgen.1004494.

Lee J-M, Kim K-H, Shin A, et al. Sequence-Level Analysis of the Major European Huntington Disease Haplotype. Am J Hum Genet. 2015;97(3):435-44. doi:10.1016/j.ajhg.2015.07.017.

Fu Q, Posth C, Hajdinjak M, et al. The genetic history of Ice Age Europe. Nature. 2016;534(7606):200-5. doi:10.1038/nature17993.